The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Disease characteristics and outcome of patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) who received a beta emitter (177Lu-PSMA) after an alpha emitter (radium-223).
 
A. Oliver Sartor
Stock and Other Ownership Interests - Abbvie; Cardinal Health; GlaxoSmithKline; Lilly; PSMA Therapeutics; United Health Group; Varian Medical Systems
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bavarian Nordic; Bayer; Blue Earth Diagnostics; Bristol-Myers Squibb; Clovis Oncology; Constellation Pharmaceuticals; Dendreon; EMD Serono; Endocyte; Johnson & Johnson; Myovant Sciences; Myriad Genetics; Novartis; Novartis; Noxopharm; Pfizer; Progenics; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Constellation Pharmaceuticals (Inst); Dendreon (Inst); Endocyte (Inst); Innocrin Pharma (Inst); InVitae (Inst); Johnson & Johnson (Inst); Merck (Inst); Sanofi (Inst); SOTIO
Expert Testimony - Sanofi
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Johnson & Johnson; Progenics; Sanofi
 
Christian la Fougère
Consulting or Advisory Role - Bayer
Research Funding - GE Healthcare; Siemens
 
Markus Essler
Consulting or Advisory Role - Bayer (I); Ipsen (I); Novartis (I)
Research Funding - Novartis
Travel, Accommodations, Expenses - Ipsen; Sirtex Medical
 
Samer Ezziddin
Travel, Accommodations, Expenses - Ipsen
 
Gero Kramer
No Relationships to Disclose
 
Jörg Ellinger
Consulting or Advisory Role - Bayer; Sanofi
 
Luke T. Nordquist
No Relationships to Disclose
 
John Sylvester
Employment - 21st Century Oncology; 21st Century Oncology
Stock and Other Ownership Interests - Augmenix; Augmenix
Honoraria - Decipher Biosciences; Decipher Biosciences; Theragenics; Theragenics
Consulting or Advisory Role - Theragenics; Theragenics
Speakers' Bureau - Theragenics; Theragenics
Research Funding - Advantagene; Prostatak via 21st Century Oncology)
Patents, Royalties, Other Intellectual Property - Myriad Pharmaceuticals; Myriad Pharmaceuticals
Travel, Accommodations, Expenses - Theragenics; Theragenics
 
Giovanni Paganelli
No Relationships to Disclose
 
Avivit Peer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Janssen-Cilag; Medison; MSD; Novartis; Pfizer; Roche
 
Martin Boegemann
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer/Vital; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; Merck; MSD; Novartis; Pfizer; Roche; Sanofi/Aventis
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; ipsen; Janssen-Cilag; Merck; MSD; Novartis; Roche; Sanofi
Research Funding - Janssen-Cilag
Travel, Accommodations, Expenses - Amgen; Bayer; Janssen-Cilag
 
Jeffrey Meltzer
Employment - Bayer
 
Per Sandstrom
Employment - Bayer
 
Danny Song
Stock and Other Ownership Interests - Roche
Consulting or Advisory Role - BioProtect
Research Funding - Bristol-Myers Squibb